Samsung Epis Holdings Co Ltd
0126Z0
Company Profile
Business description
Samsung Epis Holdings Co Ltd focuses on the development and commercialization of biopharmaceuticals. The company is engaged in development and commercialization of biosimilars, concentrating on various disease areas including autoimmune diseases, oncology, ophthalmic diseases, hematological diseases, and bone diseases.
Contact
76 Songdogyuk-ro
Yeonsu-gu
Incheon
KORT: +82 327280114
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Why stocks sometimes fall for no obvious reason
How the private markets impact all equity investors.
stocks
Poor organic growth obscured by acquisition for ASX listed share
Sales dropped by 2% without impact of acquisition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,887.30 | 4.90 | -0.06% |
| CAC 40 | 8,086.00 | 31.42 | -0.39% |
| DAX 40 | 24,606.77 | 130.47 | -0.53% |
| Dow JONES (US) | 50,285.66 | 276.31 | 0.55% |
| FTSE 100 | 10,443.47 | 11.13 | 0.11% |
| HKSE | 25,657.87 | 271.35 | 1.07% |
| NASDAQ | 26,293.10 | 22.74 | 0.09% |
| Nikkei 225 | 63,175.11 | 1,490.97 | 2.42% |
| NZX 50 Index | 12,923.41 | 45.34 | 0.35% |
| S&P 500 | 7,445.72 | 12.75 | 0.17% |
| S&P/ASX 200 | 8,666.10 | 6.00 | -0.07% |
| SSE Composite Index | 4,096.24 | 18.96 | 0.47% |